Covered recipient · General Payments record

GERONIMO E BANAYAT

Allopathic & Osteopathic Physicians Internal Medicine

NPI: 1376620500
CMS profile: 544788
Location: CLARK, NJ

General Payments · PY2018–2024

$2,644.40

Reported across 156 records
CMS publication 2026-01-23

Latest program year · PY2024

$937.57

54 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of payment	Amount	Records
Food and Beverage	$912.96	53
Education	$24.61	1

By paying entity

PY2024 · sorted by reported total

Paying entity	Amount	Records
NOVARTIS PHARMACEUTICALS CORPORATION	$229.44	9
Relypsa, Inc.	$160.94	11
AKEBIA THERAPEUTICS INC	$75.68	4
Acerta Pharma LLC	$61.50	4
Novo Nordisk AS	$51.11	3
ANI Pharmaceuticals, Inc.	$48.08	3
CALLIDITAS THERAPEUTICS US INC.	$47.23	3
Otsuka America Pharmaceutical, Inc.	$42.35	3
Xeris Pharmaceuticals, Inc.	$32.72	2
Mallinckrodt Hospital Products Inc.	$32.35	2
Salix Pharmaceuticals, a division of Bausch Health US, LLC	$31.10	2
Amgen Inc.	$29.25	2
Lilly USA, LLC	$28.60	2
Ardelyx, Inc.	$28.25	2
Abbott Laboratories	$22.36	1
Bayer HealthCare Pharmaceuticals Inc.	$16.61	1

By program year

All program years on this page · sorted by year

Program year	Amount	Records
PY2018	$234.47	16
PY2019	$71.99	5
PY2020	$153.73	6
PY2021	$212.63	14
PY2022	$441.30	26
PY2023	$592.71	35
PY2024	$937.57	54

Payment records · PY2024 (54)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018 2019 2020 2021 2022 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.

Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Record ID	Source
Abbott Laboratories	$22.36	03/13/2024	Food and Beverage	Undisputed	01/23/2026	1125034768	CMS
AKEBIA THERAPEUTICS INC	$18.80	08/08/2024	Food and Beverage	Undisputed	01/23/2026	1145826892	CMS
AKEBIA THERAPEUTICS INC	$17.52	10/22/2024	Food and Beverage	Undisputed	01/23/2026	1145829753	CMS
AKEBIA THERAPEUTICS INC	$14.75	11/19/2024	Food and Beverage	Undisputed	01/23/2026	1145831401	CMS
AKEBIA THERAPEUTICS INC	$24.61	11/19/2024	Education	Undisputed	01/23/2026	1145834435	CMS
Amgen Inc.	$14.78	04/11/2024	Food and Beverage	Undisputed	01/23/2026	1117197079	CMS
Amgen Inc.	$14.47	09/17/2024	Food and Beverage	Undisputed	01/23/2026	1117197081	CMS
ANI Pharmaceuticals, Inc.	$17.20	01/25/2024	Food and Beverage	Undisputed	01/23/2026	1091154104	CMS
ANI Pharmaceuticals, Inc.	$14.42	07/16/2024	Food and Beverage	Undisputed	01/23/2026	1091156542	CMS
ANI Pharmaceuticals, Inc.	$16.46	09/16/2024	Food and Beverage	Undisputed	01/23/2026	1091155270	CMS
Ardelyx, Inc.	$14.95	05/30/2024	Food and Beverage	Undisputed	01/23/2026	1146670343	CMS
Ardelyx, Inc.	$13.30	08/22/2024	Food and Beverage	Undisputed	01/23/2026	1146670345	CMS
AstraZeneca Pharmaceuticals LP	$14.46	03/20/2024	Food and Beverage	Undisputed	01/23/2026	1104236047	CMS
AstraZeneca Pharmaceuticals LP	$15.59	05/21/2024	Food and Beverage	Undisputed	01/23/2026	1104337972	CMS
AstraZeneca Pharmaceuticals LP	$15.02	06/20/2024	Food and Beverage	Undisputed	01/23/2026	1105665836	CMS
AstraZeneca Pharmaceuticals LP	$16.43	08/28/2024	Food and Beverage	Undisputed	01/23/2026	1105646386	CMS
Bayer Healthcare Pharmaceuticals Inc.	$16.61	02/08/2024	Food and Beverage	Undisputed	01/23/2026	1086249352	CMS
CALLIDITAS THERAPEUTICS US INC.	$14.12	02/28/2024	Food and Beverage	Undisputed	01/23/2026	1141510296	CMS
CALLIDITAS THERAPEUTICS US INC.	$16.41	06/19/2024	Food and Beverage	Undisputed	01/23/2026	1141517219	CMS
CALLIDITAS THERAPEUTICS US INC.	$16.70	10/07/2024	Food and Beverage	Undisputed	01/23/2026	1141524124	CMS
Lilly USA, LLC	$14.96	05/16/2024	Food and Beverage	Undisputed	01/23/2026	1135007889	CMS
Lilly USA, LLC	$13.64	07/23/2024	Food and Beverage	Undisputed	01/23/2026	1135000974	CMS
Mallinckrodt Hospital Products Inc.	$13.83	01/09/2024	Food and Beverage	Undisputed	01/23/2026	1145048641	CMS
Mallinckrodt Hospital Products Inc.	$18.52	06/17/2024	Food and Beverage	Undisputed	01/23/2026	1145048643	CMS
Novartis Pharmaceuticals Corporation	$11.05	01/11/2024	Food and Beverage	Undisputed	01/23/2026	1086689201	CMS
Novartis Pharmaceuticals Corporation	$14.74	01/23/2024	Food and Beverage	Undisputed	01/23/2026	1086689205	CMS
Novartis Pharmaceuticals Corporation	$12.92	02/06/2024	Food and Beverage	Undisputed	01/23/2026	1086689203	CMS
Novartis Pharmaceuticals Corporation	$135.36	02/28/2024	Food and Beverage	Undisputed	01/23/2026	1086689207	CMS
Novartis Pharmaceuticals Corporation	$16.98	04/17/2024	Food and Beverage	Undisputed	01/23/2026	1086689211	CMS
Novartis Pharmaceuticals Corporation	$4.43	04/24/2024	Food and Beverage	Undisputed	01/23/2026	1086689209	CMS
Novartis Pharmaceuticals Corporation	$16.12	07/18/2024	Food and Beverage	Undisputed	01/23/2026	1086689213	CMS
Novartis Pharmaceuticals Corporation	$16.86	11/12/2024	Food and Beverage	Undisputed	01/23/2026	1086689215	CMS
Novartis Pharmaceuticals Corporation	$0.98	11/12/2024	Food and Beverage	Undisputed	01/23/2026	1086689217	CMS
Novo Nordisk Inc	$16.68	04/19/2024	Food and Beverage	Undisputed	01/23/2026	1097657940	CMS
Novo Nordisk Inc	$16.85	07/25/2024	Food and Beverage	Undisputed	01/23/2026	1096860442	CMS
Novo Nordisk Inc	$17.58	10/15/2024	Food and Beverage	Undisputed	01/23/2026	1096787970	CMS
Otsuka America Pharmaceutical, Inc.	$14.32	03/20/2024	Food and Beverage	Undisputed	01/23/2026	1118858055	CMS
Otsuka America Pharmaceutical, Inc.	$14.14	07/11/2024	Food and Beverage	Undisputed	01/23/2026	1118858057	CMS
Otsuka America Pharmaceutical, Inc.	$13.89	08/16/2024	Food and Beverage	Undisputed	01/23/2026	1118858059	CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC	$15.51	09/18/2024	Food and Beverage	Undisputed	01/23/2026	1153496118	CMS
Salix Pharmaceuticals, a division of Bausch Health US, LLC	$15.59	10/04/2024	Food and Beverage	Undisputed	01/23/2026	1153645556	CMS
Vifor Pharma, Inc.	$16.51	02/20/2024	Food and Beverage	Undisputed	01/23/2026	1124046452	CMS
Vifor Pharma, Inc.	$8.24	04/11/2024	Food and Beverage	Undisputed	01/23/2026	1124034252	CMS
Vifor Pharma, Inc.	$16.43	04/22/2024	Food and Beverage	Undisputed	01/23/2026	1124041993	CMS
Vifor Pharma, Inc.	$14.00	05/11/2024	Food and Beverage	Undisputed	01/23/2026	1124040225	CMS
Vifor Pharma, Inc.	$14.47	05/13/2024	Food and Beverage	Undisputed	01/23/2026	1124040327	CMS
Vifor Pharma, Inc.	$13.09	06/07/2024	Food and Beverage	Undisputed	01/23/2026	1124053271	CMS
Vifor Pharma, Inc.	$15.87	07/16/2024	Food and Beverage	Undisputed	01/23/2026	1124047964	CMS
Vifor Pharma, Inc.	$16.58	07/19/2024	Food and Beverage	Undisputed	01/23/2026	1124051148	CMS
Vifor Pharma, Inc.	$16.91	08/13/2024	Food and Beverage	Undisputed	01/23/2026	1124052669	CMS
Vifor Pharma, Inc.	$13.05	08/14/2024	Food and Beverage	Undisputed	01/23/2026	1124052795	CMS
Vifor Pharma, Inc.	$15.79	10/21/2024	Food and Beverage	Undisputed	01/23/2026	1124064153	CMS
Xeris Pharmaceuticals, Inc.	$16.18	02/22/2024	Food and Beverage	Undisputed	01/23/2026	1144595494	CMS
Xeris Pharmaceuticals, Inc.	$16.54	08/20/2024	Food and Beverage	Undisputed	01/23/2026	1144595496	CMS

Source & provenance

Dataset: CMS Open Payments — General Payments
Publisher of source data: Centers for Medicare & Medicaid Services
CMS publication date: 2026-01-23
Program years on this page: 2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files: Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.